Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
FBT vs WDNA
Shared holdings
21
FBT covered by WDNA
28.71%
WDNA covered by FBT
28.71%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 32 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
FBT (March 31, 2026)
| Security | Weight | |
|---|---|---|
| MODERNA INC | 5.26% | |
| UNITED THERAPEUTICS CORP DEL | 4.36% | |
| ALKERMES PLC | 4.23% | |
| GILEAD SCIENCES INC | 4.09% | |
| AXSOME THERAPEUTICS INC | 3.88% | |
| AMGEN INC | 3.83% | |
| CORCEPT THERAPEUTICS INC | 3.82% | |
| KRYSTAL BIOTECH INC | 3.51% | |
| BIOGEN INC | 3.47% | |
| EXELIXIS INC | 3.46% | |
| NEUROCRINE BIOSCIENCES INC | 3.44% | |
| REGENERON PHARMACEUTICALS INC | 3.44% | |
| VERTEX PHARMACEUTICALS INC | 3.42% | |
| BIOMARIN PHARMACEUTICAL INC | 3.40% | |
| ARGENX SE SPONSORED ADR | 3.29% | |
| SAREPTA THERAPEUTICS INC | 3.24% | |
| HALOZYME THERAPEUTICS INC | 3.17% | |
| BIONTECH SE ADR | 3.16% | |
| INCYTE CORP | 3.13% | |
| BEONE MEDICINES LTD ADR | 3.12% | |
| ILLUMINA INC | 3.10% | |
| NATERA INC | 3.03% | |
| ACADIA PHARMACEUTICALS INC | 2.95% | |
| ALNYLAM PHARMACEUTICALS INC | 2.95% | |
| BIO-TECHNE CORP | 2.82% | |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 2.78% | |
| VERACYTE INC | 2.72% | |
| REPLIGEN CORP | 2.51% | |
| BRUKER CORP | 2.35% | |
| NEOGENOMICS INC | 2.00% | |
| DREY-GVT CSH-I | 0.06% | |
| DAIWA CAPITAL MARKETS AMERICA INC | 0.01% |
WDNA (March 31, 2026)
| Security | Weight | |
|---|---|---|
| MODERNA INC | 4.53% | |
| JOHNSON&JOHNSON | 3.15% | |
| UNITED THERAPEUTICS CORP DEL | 2.80% | |
| PFIZER INC | 2.73% | |
| LILLY ELI and CO | 2.64% | |
| STOKE THERAPEUTICS INC | 2.52% | |
| NATERA INC | 2.52% | |
| AMGEN INC | 2.34% | |
| TWIST BIOSCIENCE CORP | 2.31% | |
| ASTRAZENECA PLC | 2.28% | |
| STRUCTURE THERAPEUTICS INC ADR | 2.20% | |
| AMICUS THERAPEUTICS INC | 2.19% | |
| BIONTECH SE ADR | 2.09% | |
| IONIS PHARMACEUTICALS INC | 2.06% | |
| GILEAD SCIENCES INC | 1.95% | |
| CRISPR THERAPEUTICS AG | 1.87% | |
| IMMUNOME INC | 1.86% | |
| NOVOZYMES A S | 1.85% | |
| BEAM THERAPEUTICS INC | 1.81% | |
| 10X GENOMICS INC | 1.78% | |
| DARLING INGREDIENTS INC | 1.70% | |
| Novartis AG (Registered) | 1.64% | |
| ROIVANT SCIENCES LTD | 1.60% | |
| KRYSTAL BIOTECH INC | 1.57% | |
| AGIOS PHARMACEUTICALS INC | 1.56% | |
| BUNGE GLOBAL SA | 1.54% | |
| NOVO NORDISK-B | 1.48% | |
| INTELLIA THERAPEUTICS INC | 1.48% | |
| CORTEVA INC | 1.45% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.43% | |
| VERTEX PHARMACEUTICALS INC | 1.36% | |
| REGENXBIO INC | 1.32% | |
| ARCELLX INC | 1.28% | |
| ALLOGENE THERAPEUTICS INC | 1.24% | |
| BRISTOL-MYERS SQUIBB CO | 1.19% | |
| TAKEDA PHARMACEU | 1.16% | |
| REGENERON PHARMACEUTICALS INC | 1.12% | |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 1.10% | |
| VERBIO VEREINI | 1.04% | |
| BIOMARIN PHARMACEUTICAL INC | 1.02% | |
| Bayer Aktiengesellschaft | 1.01% | |
| ARGENX SE SPONSORED ADR | 0.93% | |
| VIKING THERAPEUTICS INC | 0.91% | |
| VERACYTE INC | 0.90% | |
| EDITAS MEDICINE INC | 0.89% | |
| DANAHER CORP | 0.89% | |
| ARCTURUS THERAPEUTICS HOLDINGS INC | 0.85% | |
| ABSCI CORP | 0.84% | |
| IOVANCE BIOTHERAPEUTICS INC | 0.82% | |
| TEMPUS AI INC-A | 0.78% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.